OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib
Sz‐Tsan Wang, Chih‐Wei Tseng, Chia‐Wen Hsu, et al.
International Journal of Rheumatic Diseases (2021) Vol. 24, Iss. 11, pp. 1362-1369
Closed Access | Times Cited: 30
Sz‐Tsan Wang, Chih‐Wei Tseng, Chia‐Wen Hsu, et al.
International Journal of Rheumatic Diseases (2021) Vol. 24, Iss. 11, pp. 1362-1369
Closed Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
G. Fragoulis, Elena Nikiphorou, Mrinalini Dey, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 6, pp. 742-753
Open Access | Times Cited: 103
G. Fragoulis, Elena Nikiphorou, Mrinalini Dey, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 6, pp. 742-753
Open Access | Times Cited: 103
Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
G. Fragoulis, Mrinalini Dey, Sizheng Steven Zhao, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002726-e002726
Open Access | Times Cited: 29
G. Fragoulis, Mrinalini Dey, Sizheng Steven Zhao, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002726-e002726
Open Access | Times Cited: 29
Management of hepatitis B virus reactivation due to treatment of COVID-19
Terry Cheuk‐Fung Yip, Madeleine Gill, Grace Lai‐Hung Wong, et al.
Hepatology International (2022) Vol. 16, Iss. 2, pp. 257-268
Open Access | Times Cited: 27
Terry Cheuk‐Fung Yip, Madeleine Gill, Grace Lai‐Hung Wong, et al.
Hepatology International (2022) Vol. 16, Iss. 2, pp. 257-268
Open Access | Times Cited: 27
AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals
Faisal S. Ali, Mindie H. Nguyen, Rubén Hernáez, et al.
Gastroenterology (2025) Vol. 168, Iss. 2, pp. 267-284
Closed Access
Faisal S. Ali, Mindie H. Nguyen, Rubén Hernáez, et al.
Gastroenterology (2025) Vol. 168, Iss. 2, pp. 267-284
Closed Access
COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature
Caterina Sagnelli, Laura Montella, Pierantonio Grimaldi, et al.
Pathogens (2022) Vol. 11, Iss. 7, pp. 816-816
Open Access | Times Cited: 24
Caterina Sagnelli, Laura Montella, Pierantonio Grimaldi, et al.
Pathogens (2022) Vol. 11, Iss. 7, pp. 816-816
Open Access | Times Cited: 24
DNA Methylation of T Lymphocytes as a Therapeutic Target: Implications for Rheumatoid Arthritis Etiology
Jianan Zhao, Kai Wei, Cen Chang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Jianan Zhao, Kai Wei, Cen Chang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies
Shubha Bhat, Benjamin Click, Miguel Regueiro
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 5, pp. 829-843
Closed Access | Times Cited: 10
Shubha Bhat, Benjamin Click, Miguel Regueiro
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 5, pp. 829-843
Closed Access | Times Cited: 10
Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 1983-2038
Open Access | Times Cited: 3
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 1983-2038
Open Access | Times Cited: 3
Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
Wenxin Zhang, Xiangqian Li, Chen Bai-fu, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 16
Wenxin Zhang, Xiangqian Li, Chen Bai-fu, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 16
Actualización de las Guías para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología 2023
Carlos Abud‐Mendoza, Francisco Javier Aceves‐Ávila, César Alejandro Arce-Salinas, et al.
Reumatología Clínica (2024) Vol. 20, Iss. 5, pp. 263-280
Closed Access | Times Cited: 2
Carlos Abud‐Mendoza, Francisco Javier Aceves‐Ávila, César Alejandro Arce-Salinas, et al.
Reumatología Clínica (2024) Vol. 20, Iss. 5, pp. 263-280
Closed Access | Times Cited: 2
Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023
Carlos Abud‐Mendoza, Francisco Javier Aceves‐Ávila, César Alejandro Arce-Salinas, et al.
Reumatología Clínica (English Edition) (2024) Vol. 20, Iss. 5, pp. 263-280
Closed Access | Times Cited: 1
Carlos Abud‐Mendoza, Francisco Javier Aceves‐Ávila, César Alejandro Arce-Salinas, et al.
Reumatología Clínica (English Edition) (2024) Vol. 20, Iss. 5, pp. 263-280
Closed Access | Times Cited: 1
Tofacitinib for sarcoidosis, a new potential treatment
Qiang Xu, Zhi‐Shan Huang, Qing‐Ping Liu, et al.
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 11, pp. 1217-1219
Closed Access | Times Cited: 7
Qiang Xu, Zhi‐Shan Huang, Qing‐Ping Liu, et al.
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 11, pp. 1217-1219
Closed Access | Times Cited: 7
Hepatitis B virus reactivation associated with Janus kinase (JAK) inhibitors: a retrospective study of pharmacovigilance databases and review of the literature
Chen Pan, Mingnan Cao, Cilin Yan, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 6, pp. 469-476
Closed Access | Times Cited: 2
Chen Pan, Mingnan Cao, Cilin Yan, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 6, pp. 469-476
Closed Access | Times Cited: 2
Recomendaciones SER sobre la gestión de riesgo del tratamiento con FAME biológicos o sintéticos dirigidos en pacientes con artritis reumatoide
Alejandro Balsa, Petra Díaz del Campo Fontecha, Lucía Silva-Fernández, et al.
Reumatología Clínica (2023) Vol. 19, Iss. 10, pp. 533-548
Closed Access | Times Cited: 2
Alejandro Balsa, Petra Díaz del Campo Fontecha, Lucía Silva-Fernández, et al.
Reumatología Clínica (2023) Vol. 19, Iss. 10, pp. 533-548
Closed Access | Times Cited: 2
Healthcare Professionals’ Compliance with the Standard Management Guidelines towards the Use of Biological Disease-Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis Patients
Sadia Shakeel, Wajiha Iffat, Ambreen Qamar, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4699-4699
Open Access | Times Cited: 4
Sadia Shakeel, Wajiha Iffat, Ambreen Qamar, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4699-4699
Open Access | Times Cited: 4
Tofacitinib in the treatment of ulcerative colitis
Maximilian Kutschera, Gottfried Novacek, Walter Reinisch, et al.
Wiener klinische Wochenschrift (2022) Vol. 135, Iss. 1-2, pp. 1-13
Open Access | Times Cited: 4
Maximilian Kutschera, Gottfried Novacek, Walter Reinisch, et al.
Wiener klinische Wochenschrift (2022) Vol. 135, Iss. 1-2, pp. 1-13
Open Access | Times Cited: 4
Entzündlich-rheumatische Erkrankungen im Kontext von HIV, Hepatitis B und C
Nadine Al-Azem, Ruth C. Dartsch, Mirko Steinmüller, et al.
Aktuelle Rheumatologie (2024) Vol. 49, Iss. 02, pp. 92-97
Closed Access
Nadine Al-Azem, Ruth C. Dartsch, Mirko Steinmüller, et al.
Aktuelle Rheumatologie (2024) Vol. 49, Iss. 02, pp. 92-97
Closed Access
Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review
Г. И. Гриднева, Б. С. Белов, E. S. Aronova
Terapevticheskii arkhiv (2024) Vol. 96, Iss. 5, pp. 523-530
Open Access
Г. И. Гриднева, Б. С. Белов, E. S. Aronova
Terapevticheskii arkhiv (2024) Vol. 96, Iss. 5, pp. 523-530
Open Access
Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors
Θεόδωρος Ανδρουτσάκος, K. Dimitriadis, Maria-Loukia Koutsompina, et al.
Lara D. Veeken (2024)
Closed Access
Θεόδωρος Ανδρουτσάκος, K. Dimitriadis, Maria-Loukia Koutsompina, et al.
Lara D. Veeken (2024)
Closed Access
Pharmacological considerations in pharmacotherapy of rheumatology patients with liver disease: a brief narrative review
Saeedeh Shenavandeh, Seyed Alireza Taghavi, Ali Akbar Nekooeian, et al.
Reumatologia/Rheumatology (2024) Vol. 62, Iss. 4, pp. 282-293
Open Access
Saeedeh Shenavandeh, Seyed Alireza Taghavi, Ali Akbar Nekooeian, et al.
Reumatologia/Rheumatology (2024) Vol. 62, Iss. 4, pp. 282-293
Open Access
Pharmacovigilance study of tyrosine kinase inhibitors: Analysis of adverse reactions
A Rangelov, Georgi Momekov, Iva Parvova, et al.
Pharmacia (2024) Vol. 71, pp. 1-7
Open Access
A Rangelov, Georgi Momekov, Iva Parvova, et al.
Pharmacia (2024) Vol. 71, pp. 1-7
Open Access
On the issue of screening and prevention of chronic and opportunistic infections in rheumatology
Б. С. Белов, Г. И. Гриднева, E. S. Aronova, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2023) Vol. 68, Iss. 1-2, pp. 69-76
Open Access | Times Cited: 1
Б. С. Белов, Г. И. Гриднева, E. S. Aronova, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2023) Vol. 68, Iss. 1-2, pp. 69-76
Open Access | Times Cited: 1
Reactivation of Chronic Hepatitis B in a Patient with Rheumatoid Arthritis
Г. И. Гриднева, Б. С. Белов, E. S. Aronova
Effective Pharmacotherapy (2023) Vol. 19, Iss. 9, pp. 6-11
Open Access | Times Cited: 1
Г. И. Гриднева, Б. С. Белов, E. S. Aronova
Effective Pharmacotherapy (2023) Vol. 19, Iss. 9, pp. 6-11
Open Access | Times Cited: 1
Chronic hepatitis B in hospitalized rheumatologic patients: problems of screening and reactivation of infection
Г. И. Гриднева, E. S. Aronova, Б. С. Белов
Modern Rheumatology Journal (2023) Vol. 17, Iss. 5, pp. 67-72
Open Access | Times Cited: 1
Г. И. Гриднева, E. S. Aronova, Б. С. Белов
Modern Rheumatology Journal (2023) Vol. 17, Iss. 5, pp. 67-72
Open Access | Times Cited: 1
Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks
Sara Massironi, Lorena Pirola, Giacomo Mulinacci, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 9, pp. 1477-1487
Closed Access | Times Cited: 2
Sara Massironi, Lorena Pirola, Giacomo Mulinacci, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 9, pp. 1477-1487
Closed Access | Times Cited: 2
